Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Equity Ratio (2016 - 2025)

vTv Therapeutics' Equity Ratio history spans 12 years, with the latest figure at 0.71 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 70.85% year-over-year to 0.71; the TTM value through Sep 2025 reached 0.71, up 70.85%, while the annual FY2024 figure was 0.32, 114.23% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.71 at vTv Therapeutics, up from 0.09 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.71 in Q3 2025 and bottomed at 3.36 in Q1 2021.
  • The 5-year median for Equity Ratio is 0.38 (2021), against an average of 0.58.
  • The largest annual shift saw Equity Ratio tumbled 593.22% in 2023 before it soared 172.04% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.38 in 2021, then rose by 15.49% to 0.32 in 2022, then crashed by 593.22% to 2.24 in 2023, then skyrocketed by 114.23% to 0.32 in 2024, then skyrocketed by 122.41% to 0.71 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Equity Ratio are 0.71 (Q3 2025), 0.09 (Q2 2025), and 0.28 (Q1 2025).